Medicare Enrolled
Dr. Patrick McElgunn, M.D.
Dermatology · Charlotte, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. McElgunn from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McElgunn?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. McElgunn
Dr. Patrick McElgunn is a dermatology specialist in Charlotte, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. McElgunn performed 9,737 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. McElgunn received a total of $593,157 from 40 pharmaceutical and/or device companies across 979 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. McElgunn is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 7% volume in NC
$593,157 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗9,737
Medicare services
Top 7% in NC for dermatology
Not available
Unique patients (not deduplicated)
$45
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
3,885 | $5 | $16 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,766 | $58 | $217 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
1,030 | $38 | $160 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
396 | $75 | $271 |
| Ultrasound guidance for radiation therapy field placement Use of ultrasound imaging to help position radiation therapy fields accurately during treatment. |
378 | $136 | $426 |
| Radiation treatment planning, 1 area This procedure involves gathering the necessary data to design the most effective radiation therapy plan for a single treatment area. |
376 | $204 | $637 |
| Superficial or low voltage radiation treatment A radiation therapy procedure that delivers radiation to the surface of the body or uses low voltage energy. This treatment targets areas close to the skin. |
359 | $31 | $96 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
332 | $63 | $242 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
271 | $34 | $135 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
193 | $68 | $268 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
189 | $86 | $307 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
82 | $37 | $120 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
67 | $115 | $404 |
| Radiation treatment management, 5 sessions Oversight and management of a radiation therapy course consisting of five treatment sessions. |
56 | $147 | $463 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
46 | $10 | $34 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
41 | $2 | $6 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
38 | $207 | $727 |
| Chemotherapy administration, 1-7 injections This procedure involves the administration of chemotherapy medication through one to seven separate injections. |
38 | $50 | $199 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
33 | $94 | $587 |
| Surgical removal of skin cancer, 2.1-3.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters. |
30 | $107 | $669 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
28 | $47 | $173 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
27 | $109 | $400 |
| Complicated wound repair, scalp/arms/legs, 2.6-7.5 cm A complex surgical procedure to close a wound on the scalp, arms, or legs that measures between 2.6 and 7.5 centimeters in length. |
23 | $328 | $1,020 |
| Calculation of radiation therapy dose | 23 | $51 | $158 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
17 | $60 | $231 |
| Complicated wound repair of trunk, 2.6-7.5 cm A surgical procedure to close a complex wound on the trunk that measures between 2.6 and 7.5 centimeters in length. |
13 | $306 | $954 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$593,157
Total received (2018-2024)
Avg $84,737/year across 7 years
Top 1% in NC for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
979
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$103,632
2023
$129,329
2022
$55,295
2021
$49,720
2020
$37,127
2019
$115,076
2018
$102,978
Payments by company (2024)
Galderma Laboratories, L.P.
$23,058
UCB, Inc.
$22,006
Dermavant Sciences, Inc.
$11,900
E.R. Squibb & Sons, L.L.C.
$11,064
GENZYME CORPORATION
$10,125
PFIZER INC.
$9,948
ABBVIE INC.
$8,599
Regeneron Healthcare Solutions, Inc.
$6,052
Arcutis Biotherapeutics, Inc.
$299
SUN PHARMACEUTICAL INDUSTRIES INC.
$235
Janssen Biotech, Inc.
$206
LEO Pharma Inc.
$67
Medimetriks Pharmaceuticals, Inc.
$32
Ortho Dermatologics, a division of Bausch Health US, LLC
$24
Novartis Pharmaceuticals Corporation
$19
Top 3 companies account for 55.0% of 2024 payments
All-time payments by company (2018-2024) ›
Galderma Laboratories, L.P.
$77,199
GENZYME CORPORATION
$64,888
Novartis Pharmaceuticals Corporation
$59,792
Dermavant Sciences, Inc.
$58,685
Celgene Corporation
$45,561
E.R. Squibb & Sons, L.L.C.
$38,191
AbbVie, Inc.
$37,449
Regeneron Healthcare Solutions, Inc.
$37,276
PFIZER INC.
$32,945
UCB, Inc.
$29,987
ABBVIE INC.
$29,475
Amgen Inc.
$24,109
Almirall LLC
$23,498
AbbVie Inc.
$13,253
Promius Pharma LLC
$4,338
Allergan Inc.
$3,995
Incyte Corporation
$3,047
Janssen Biotech, Inc.
$2,683
Arcutis Biotherapeutics, Inc.
$2,528
Journey Medical Corporation
$678
Medimetriks Pharmaceuticals, Inc.
$557
Janssen Scientific Affairs, LLC
$552
LEO Pharma Inc.
$479
Sun Pharmaceutical Industries Inc.
$404
Allergan, Inc.
$377
EPI Health, LLC
$338
SUN PHARMACEUTICAL INDUSTRIES INC.
$306
Lilly USA, LLC
$109
Ortho Dermatologics, a division of Bausch Health US, LLC
$91
Biofrontera Inc.
$77
Genentech USA, Inc.
$73
STRATA Skin Sciences, Inc.
$48
Mayne Pharma Inc.
$44
Verrica Pharmaceuticals Inc.
$26
ANI Pharmaceuticals, Inc.
$23
DUSA Pharmaceuticals, Inc.
$23
MAYNE PHARMA INC.
$14
Helsinn Therapeutics (U.S.), Inc.
$14
SANOFI-AVENTIS U.S. LLC
$14
Mylan Pharmaceuticals Inc.
$11
Top 3 companies account for 34.0% of all-time payments
Associated products mentioned in payments ›
ABSORICA · ADBRY · AKLIEF · AMELUZ · Ameluz · BLU-U · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · BOTOX · BOTOX COSMETIC · BRYHALI · Bensal HP · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cabtreo · Ceracade · Cimzia · Clindacin ETZ · Clindacin P · Clindamycin Phosphate and Benzoyl Peroxide · Clodan · Cloderm Cream · DORYX · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dermatological Psoriasis and Vitiligo Treatment · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Enbrel · Erivedge · Exelderm · Genadur · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · JUBLIA · NATRELLE · Neo-Synalar · Neo-Synalar Cream · Neuac · Neuac Gel · OPZELURA · Odomzo · Otezla · Oxistat · QBREXZA · REMICADE · RINVOQ · SEYSARA · SKYRIZI · SOOLANTRA · Sernivo Spray · Seysara · Skyrizi · Sotyktu · TALTZ · TREMFYA · TRIANEX 0.05% · TargaDox · Tovet (emollient formulation) · Tremfya · Trianex · VALCHLOR · VTAMA · Winlevi · XTRAC · YCANTH · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Dermatologists in nearby ZIP areas
73
County median income
$83,765
Nearest hospital to ZIP centroid (approximate)
NOVANT HEALTH BALLANTYNE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. McElgunn is a clinical cardiology specialist, with above-average Medicare volume (top 7% in NC), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. McElgunn experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. McElgunn performed 3,885 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. McElgunn receive payments from pharmaceutical companies?
Yes. Dr. McElgunn received a total of $593,157 from 40 companies across 979 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McElgunn's costs compare to other dermatologists in Charlotte?
Dr. McElgunn's average Medicare payment per service is $45. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McElgunn) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Charlotte
Browse dermatologists in Charlotte ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in NC
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in NC
Which NC dermatologists receive the most from drug and device companies.
By company
Galderma Laboratories, L.P. Payments to Doctors
See all physicians who received payments from Galderma Laboratories, L.P.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology